Eliem Therapeutics, Inc.

NasdaqGM:ELYM Stock Report

Market Cap: US$108.5m

Eliem Therapeutics Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenure1.2yrs
Board average tenure4.5yrs

Recent management updates

Recent updates

Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation

Feb 01
Here's Why We're Not Too Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Situation

We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully

Jun 24
We Think Eliem Therapeutics (NASDAQ:ELYM) Needs To Drive Business Growth Carefully

We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Mar 08
We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Nov 18
We're Not Very Worried About Eliem Therapeutics' (NASDAQ:ELYM) Cash Burn Rate

Eliem Therapeutics GAAP EPS of -$0.56 misses by $0.09

Aug 15

Eliem to discontinue development of lead asset as mid-stage pain trial fails

Aug 02

SVB Leerink cuts PT on Eliem Therapeutics, reaffirms Outperform rating

Jul 11

CEO

Eliem Therapeutics has no CEO, or we have no data on them.


Leadership Team

NamePositionTenureCompensationOwnership
Andrew Levin
Principal Financial Officer & Executive Chairman5.2yrsUS$96.34kno data
Valerie Morisset
Chief Scientific Officer and Executive VP of Research & Development5yrsUS$1.99m1.8%
$ 2.0m
Emily Pimblett
Principal Accounting Officer1.2yrsno datano data
Jo Palmer-Phillips
Chief Development Officerno datano datano data

1.2yrs

Average Tenure

45yo

Average Age

Experienced Management: ELYM's management team is not considered experienced ( 1.2 years average tenure), which suggests a new team.


Board Members

NamePositionTenureCompensationOwnership
Andrew Levin
Principal Financial Officer & Executive Chairman5.2yrsUS$96.34kno data
Adam Rosenberg
Independent Director3.5yrsUS$70.84k0.64%
$ 689.2k
Liam Ratcliffe
Lead Independent Director4.5yrsUS$68.34k0%
$ 0
Simon Tate
Independent Director5.2yrsUS$23.34k0%
$ 0
Judith Dunn
Independent Director3.2yrsUS$63.34k0%
$ 0

4.5yrs

Average Tenure

56yo

Average Age

Experienced Board: ELYM's board of directors are considered experienced (4.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.